Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

被引：198
|
作者：
Takashita, Emi [1 ]
Kinoshita, Noriko [2 ]
Yamayoshi, Seiya [3 ]
Sakai-Tagawa, Yuko [3 ]
Fujisaki, Seiichiro [1 ]
Ito, Mutsumi [3 ]
Iwatsuki-Horimoto, Kiyoko [3 ]
Halfmann, Peter [4 ]
Watanabe, Shinji [1 ]
Maeda, Kenji [2 ]
Imai, Masaki [3 ]
Mitsuya, Hiroaki [2 ]
Ohmagari, Norio [2 ]
Takeda, Makoto [1 ]
Hasegawa, Hideki [1 ]
Kawaoka, Yoshihiro [3 ]
机构：
[1] Natl Inst Infect Dis, Tokyo, Japan
[2] Natl Ctr Global Hlth & Med, Tokyo, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Univ Wisconsin, Madison, WI USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 386卷 / 15期
关键词：
D O I：
10.1056/NEJMc2201933
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1475 / 1477
页数：3
相关论文
共 50 条
  • [41] Evidence of the Clinical Efficacy of Antiviral Agents against SARS-CoV-2
    Welman, Angelique
    Outhoff, Kim
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2021, 10 (03): : 94 - 111
  • [42] Lineage BA.2 dominated the Omicron SARS-CoV-2 epidemic wave in the Philippines
    Li, Yao-Tsun
    Polotan, Francisco Gerardo M.
    Sotelo, Gerald Ivan S.
    Alpino, Anne Pauline A.
    Dolor, Ardiane Ysabelle M.
    Tujan, Ma Angelica A.
    Gomez, Ma Ricci R.
    Onza, Othoniel Jan T.
    Chang, Angela Kae T.
    Bautista, Criselda T.
    Carandang, June C.
    Yangzon, Maria Sofia L.
    Pangilinan, Elcid Aaron R.
    Mantaring, Renato Jacinto
    Telles, Alyssa Joyce E.
    Egana, John Michael C.
    Endozo, Joshua Jose S.
    Cruz, Rianna Patricia S.
    Tablizo, Francis A.
    Yap, Jan Michael C.
    Maralit, Benedict A.
    Ayes, Marc Edsel C.
    de la Paz, Eva Marie C.
    Saloma, Cynthia P.
    Lim, Dodge R.
    Dancel, Lei Lanna M.
    Uy-Lumandas, Mayan
    Medado, Inez Andrea P.
    Dizon, Timothy John R.
    Hampson, Katie
    Daldry, Simon
    Hughes, Joseph
    Brunker, Kirstyn
    VIRUS EVOLUTION, 2022, 8 (02)
  • [43] Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
    Stalls, Victoria
    Lindenberger, Jared
    Gobeil, Sophie M. -C.
    Henderson, Rory
    Parks, Rob
    Barr, Maggie
    Deyton, Margaret
    Martin, Mitchell
    Janowska, Katarzyna
    Huang, Xiao
    May, Aaron
    Speakman, Micah
    Beaudoin, Esther
    Kraft, Bryan
    Lu, Xiaozhi
    Edwards, Robert J.
    Eaton, Amanda
    Montefiori, David C.
    Williams, Wilton B.
    Saunders, Kevin O.
    Wiehe, Kevin
    Haynes, Barton F.
    Acharya, Priyamvada
    CELL REPORTS, 2022, 39 (13):
  • [44] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
    Franck Touret
    Cécile Baronti
    Boris Pastorino
    Paola Mariela Saba Villarroel
    Laetitia Ninove
    Antoine Nougairède
    Xavier de Lamballerie
    Scientific Reports, 12
  • [45] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
    Touret, Franck
    Baronti, Cecile
    Pastorino, Boris
    Villarroel, Paola Mariela Saba
    Ninove, Laetitia
    Nougairede, Antoine
    de Lamballerie, Xavier
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [46] Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England
    Elliott, Paul
    Eales, Oliver
    Steyn, Nicholas
    Tang, David
    Bodinier, Barbara
    Wang, Haowei
    Elliott, Joshua
    Whitaker, Matthew
    Atchison, Christina
    Diggle, Peter J.
    Page, Andrew J.
    Trotter, Alexander J.
    Ashby, Deborah
    Barclay, Wendy
    Taylor, Graham
    Ward, Helen
    Darzi, Ara
    Cooke, Graham S.
    Donnelly, Christl A.
    Chadeau-Hyam, Marc
    SCIENCE, 2022, 376 (6600) : 1432 - +
  • [47] Structural characteristics of the SARS-CoV-2 Omicron lineages BA.1 and BA.2 virions
    Ma, Xiaoyu
    Wang, Yanqun
    Gao, Yuanzhu
    Wang, Yiliang
    Yan, An
    Chen, Jiantao
    Zhang, Lu
    Wang, Peiyi
    Zhao, Jincun
    Liu, Zheng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [48] Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
    Hiam Chemaitelly
    Houssein H. Ayoub
    Sawsan AlMukdad
    Peter Coyle
    Patrick Tang
    Hadi M. Yassine
    Hebah A. Al-Khatib
    Maria K. Smatti
    Mohammad R. Hasan
    Zaina Al-Kanaani
    Einas Al-Kuwari
    Andrew Jeremijenko
    Anvar Hassan Kaleeckal
    Ali Nizar Latif
    Riyazuddin Mohammad Shaik
    Hanan F. Abdul-Rahim
    Gheyath K. Nasrallah
    Mohamed Ghaith Al-Kuwari
    Adeel A. Butt
    Hamad Eid Al-Romaihi
    Mohamed H. Al-Thani
    Abdullatif Al-Khal
    Roberto Bertollini
    Laith J. Abu-Raddad
    Nature Communications, 13
  • [49] Structural characteristics of the SARS-CoV-2 Omicron lineages BA.1 and BA.2 virions
    Xiaoyu Ma
    Yanqun Wang
    Yuanzhu Gao
    Yiliang Wang
    An Yan
    Jiantao Chen
    Lu Zhang
    Peiyi Wang
    Jincun Zhao
    Zheng Liu
    Signal Transduction and Targeted Therapy, 8
  • [50] Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    AlMukdad, Sawsan
    Coyle, Peter
    Tang, Patrick
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Smatti, Maria K.
    Hasan, Mohammad R.
    Al-Kanaani, Zaina
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed Ghaith
    Butt, Adeel A.
    Al-Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Al-Khal, Abdullatif
    Bertollini, Roberto
    Abu-Raddad, Laith J.
    NATURE COMMUNICATIONS, 2022, 13 (01)
12345